The silencing or knockdown of galectin-1 in vivo via intranasal administration or through siRNA-loaded chitosan lipid nanocapsule showed promising results by altering the GB TME and immune compartment and reducing TMZ resistance, unraveling galectin-1 importance in immunosuppression and tumor promotion [147,148,149]. The gene discussed is LGALS1; the disease is neoplasm.